EASY BIO,Inc. (KOSDAQ:353810)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,980.00
+90.00 (1.84%)
Apr 1, 2025, 3:30 PM KST

EASY BIO,Inc. Statistics

Total Valuation

EASY BIO,Inc. has a market cap or net worth of KRW 165.02 billion. The enterprise value is 316.97 billion.

Market Cap 165.02B
Enterprise Value 316.97B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date Mar 21, 2025
Ex-Dividend Date Dec 27, 2024

Share Statistics

EASY BIO,Inc. has 33.14 million shares outstanding. The number of shares has decreased by -0.89% in one year.

Current Share Class n/a
Shares Outstanding 33.14M
Shares Change (YoY) -0.89%
Shares Change (QoQ) -2.22%
Owned by Insiders (%) 1.34%
Owned by Institutions (%) 0.69%
Float 16.10M

Valuation Ratios

The trailing PE ratio is 8.60 and the forward PE ratio is 5.27.

PE Ratio 8.60
Forward PE 5.27
PS Ratio 0.44
PB Ratio 1.96
P/TBV Ratio 9.22
P/FCF Ratio 7.67
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.94, with an EV/FCF ratio of 14.74.

EV / Earnings 16.17
EV / Sales 0.82
EV / EBITDA 7.94
EV / EBIT 9.79
EV / FCF 14.74

Financial Position

The company has a current ratio of 1.71, with a Debt / Equity ratio of 2.36.

Current Ratio 1.71
Quick Ratio 0.82
Debt / Equity 2.36
Debt / EBITDA 5.25
Debt / FCF 9.75
Interest Coverage 3.59

Financial Efficiency

Return on equity (ROE) is 25.69% and return on invested capital (ROIC) is 9.06%.

Return on Equity (ROE) 25.69%
Return on Assets (ROA) 7.61%
Return on Invested Capital (ROIC) 9.06%
Return on Capital Employed (ROCE) 13.95%
Revenue Per Employee 2.93B
Profits Per Employee 149.65M
Employee Count 131
Asset Turnover 1.44
Inventory Turnover 7.20

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +32.88% in the last 52 weeks. The beta is 0.93, so EASY BIO,Inc.'s price volatility has been similar to the market average.

Beta (5Y) 0.93
52-Week Price Change +32.88%
50-Day Moving Average 4,892.60
200-Day Moving Average 4,260.23
Relative Strength Index (RSI) 52.92
Average Volume (20 Days) 417,683

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, EASY BIO,Inc. had revenue of KRW 384.33 billion and earned 19.60 billion in profits. Earnings per share was 579.00.

Revenue 384.33B
Gross Profit 98.09B
Operating Income 32.39B
Pretax Income 26.38B
Net Income 19.60B
EBITDA 39.90B
EBIT 32.39B
Earnings Per Share (EPS) 579.00
Full Income Statement

Balance Sheet

The company has 62.50 billion in cash and 209.63 billion in debt, giving a net cash position of -147.12 billion or -4,439.91 per share.

Cash & Cash Equivalents 62.50B
Total Debt 209.63B
Net Cash -147.12B
Net Cash Per Share -4,439.91
Equity (Book Value) 88.80B
Book Value Per Share 2,538.27
Working Capital 91.27B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 25.76 billion and capital expenditures -4.25 billion, giving a free cash flow of 21.51 billion.

Operating Cash Flow 25.76B
Capital Expenditures -4.25B
Free Cash Flow 21.51B
FCF Per Share 649.14
Full Cash Flow Statement

Margins

Gross margin is 25.52%, with operating and profit margins of 8.43% and 5.10%.

Gross Margin 25.52%
Operating Margin 8.43%
Pretax Margin 6.86%
Profit Margin 5.10%
EBITDA Margin 10.38%
EBIT Margin 8.43%
FCF Margin 5.60%

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 2.04%.

Dividend Per Share 100.00
Dividend Yield 2.04%
Dividend Growth (YoY) 100.00%
Years of Dividend Growth 2
Payout Ratio 17.41%
Buyback Yield 0.89%
Shareholder Yield 2.93%
Earnings Yield 11.88%
FCF Yield 13.03%
Dividend Details

Stock Splits

The last stock split was on December 21, 2020. It was a forward split with a ratio of 5.

Last Split Date Dec 21, 2020
Split Type Forward
Split Ratio 5

Scores

EASY BIO,Inc. has an Altman Z-Score of 2.2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.2
Piotroski F-Score n/a